Wed, October 2, 2013
Tue, October 1, 2013
Mon, September 30, 2013
Fri, September 27, 2013
Thu, September 26, 2013
Wed, September 25, 2013
Tue, September 24, 2013
Mon, September 23, 2013
Fri, September 20, 2013
Thu, September 19, 2013
Wed, September 18, 2013
Tue, September 17, 2013
Mon, September 16, 2013
Fri, September 13, 2013
Thu, September 12, 2013

Paul Matteis Maintained (ALNY) at Buy with Increased Target to $80 on, Sep 23rd, 2013

Paul Matteis of Leerink Swann, Maintained "Alnylam Pharmaceuticals, Inc." (ALNY) at Buy with Increased Target from $57 to $80 on, Sep 23rd, 2013.

Paul has made no other calls on ALNY in the last 4 months.



There are 2 other peers that have a rating on ALNY. Out of the 2 peers that are also analyzing ALNY, 0 agree with Paul's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Paul


  • Anupam Rama of "JP Morgan" Maintained at Buy with Increased Target to $55 on, Friday, July 12th, 2013
  • Edward Tenthoff of "Piper Sandler" Maintained at Buy with Increased Target to $60 on, Friday, July 12th, 2013